APA (7th ed.) Citation

Moll, G., Ankrum, J. A., Kamhieh-Milz, J., Bieback, K., Ringdén, O., Volk, H., . . . Reinke, P. (2019). Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines. Trends in molecular medicine, 25(2), 149-163. https://doi.org/10.1016/j.molmed.2018.12.006

Chicago Style (17th ed.) Citation

Moll, Guido, James A. Ankrum, Julian Kamhieh-Milz, Karen Bieback, Olle Ringdén, Hans-Dieter Volk, Sven Geissler, and Petra Reinke. "Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines." Trends in Molecular Medicine 25, no. 2 (2019): 149-163. https://doi.org/10.1016/j.molmed.2018.12.006.

MLA (9th ed.) Citation

Moll, Guido, et al. "Intravascular Mesenchymal Stromal/Stem Cell Therapy Product Diversification: Time for New Clinical Guidelines." Trends in Molecular Medicine, vol. 25, no. 2, 2019, pp. 149-163, https://doi.org/10.1016/j.molmed.2018.12.006.